UNSPSC 51171956: Plaunotol

This classification denotes an anti-ulcer agent with the molecular formula C20H34O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MV715X4634, chemically known as 2,6,10,14-hexadecatetraen-1-ol, 7-(hydroxymethyl)-3,11,15-trimethyl-, (e,z,e)- but generally known as plaunotol, which bears US NIH Compound Identifier 5282197. European Medicines Agency schedules Plaunotol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09956MIG.

UNSPSC 51171956 Plaunotol, a Commodity code, covers pharmaceutical products supplied to state and local government health systems, correctional facilities, and benefit programs. Recent solicitations show state and local buyers procuring plaunotol and related generic pharmaceuticals through bulk supply contracts, cooperative purchasing arrangements, and specimen-testing programs that incorporate pharmaceutical screening and confirmation methodologies. The issuing bodies include county criminal justice departments, state health and human services agencies, and multistate cooperative purchasing alliances serving public health systems and corrections entities. Work solicited under the code encompasses both direct pharmaceutical supply (generic multi-source products, OTC items, and lab-certified testing agents) and ancillary services such as specimen collection infrastructure and drug screening operations tied to pharmaceutical testing protocols.

Recent activity spans Texas, Minnesota, and Oregon. The Texas Health and Human Services Commission issued RFI No. HHS0017013 in March 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels, with response due April 3, 2026. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026 for offender specimen collection and drug testing services—including immunoassay screening, LC/MS/MS and GC/MS confirmation, and oral fluid and hair testing—with proposals due July 23, 2026 and an estimated contract value of $600,000 over two years plus three optional one-year renewals. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed to participating state and local government facilities in Minnesota and Oregon, with awarded vendors effective July 1, 2026 and contract terms of two years with optional extensions through June 30, 2028.